Literature DB >> 10488195

Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae.

L M Kelly1, M R Jacobs, P C Appelbaum.   

Abstract

This study evaluated the susceptibility of pneumococci to cefditoren by agar dilution and microdilution methods (both in air) and by E-test (AB Biodisk, Solna, Sweden) and disk diffusion methods (both in CO(2)). By the three MIC tests, the MICs at which 50 and 90% of isolates were inhibited (MIC(50)s and MIC(90)s) were, respectively, as follows (in micrograms per milliliter): for the 65 penicillin-susceptible strains tested, 0.016 and 0.03 (by agar dilution), 0.016 and 0.03 (by microdilution), and 0.016 and 0.03 (by E test); for the 68 penicillin-intermediate strains tested, 0.125 and 0.5 (by agar dilution), 0.125 and 0.5 (by microdilution), and 0. 25 and 0.5 (by E test); and for the 67 penicillin-resistant strains tested, 1.0 and 1.0 (by agar dilution), 0.5 and 1.0 (by microdilution), and 1.0 and 1.0 (by E test). With tentative cefditoren breakpoints (in micrograms per milliliter) of </=2.0 (susceptible), 4.0 (intermediate), and >/=8.0 (resistant), all strains were susceptible to cefditoren by agar, microdilution, and E-test results; with breakpoints of </=1.0, 2.0, and >/=4.0 microg/ml, 97% of strains were cefditoren susceptible by agar dilution results, 98% were susceptible by microdilution results, and 99% were susceptible by E-test results. When microdilution and E-test results were compared to those from the reference agar dilution method, 191 (95.5%) and 183 (91.5%) of strains gave essential agreement (+/-1 log(2) dilution); 8 (2.7%) minor discrepancies were found for both methods with a breakpoint of </=1. 0 microg/ml, and no discrepancies were found with a breakpoint of </=2.0 microg/ml. Disk test results (breakpoint, </=1.0 microg/ml) produced 2 major and 30 minor errors, with corresponding zone diameters (in millimeters) of >/=20 (susceptible), 17 to 19 (intermediate), and </=16 (resistant); a </=2.0-microg/ml breakpoint yielded zone diameters of >/=16 mm (susceptible). All three methods for testing the MIC of cefditoren showed excellent correlation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488195      PMCID: PMC85550          DOI: 10.1128/JCM.37.10.3296-3299.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.

Authors:  J Liñares; T Alonso; J L Pérez; J Ayats; M A Domínguez; R Pallarés; R Martín
Journal:  J Antimicrob Chemother       Date:  1992-09       Impact factor: 5.790

2.  Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis.

Authors:  R Munoz; J M Musser; M Crain; D E Briles; A Marton; A J Parkinson; U Sorensen; A Tomasz
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

3.  In vitro antibacterial activity of ME1207, a new oral cephalosporin.

Authors:  S Miyazaki; Y Miyazaki; A Tsuji; M Nishida; S Goto
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

4.  Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors:  C L Clark; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

5.  In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin.

Authors:  A Tamura; R Okamoto; T Yoshida; H Yamamoto; S Kondo; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

6.  Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

7.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

8.  Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment.

Authors:  C T Nelson; E O Mason; S L Kaplan
Journal:  Pediatr Infect Dis J       Date:  1994-07       Impact factor: 2.129

10.  In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

Authors:  R N Jones; D J Biedenbach; M A Croco; M S Barrett
Journal:  Diagn Microbiol Infect Dis       Date:  1998-08       Impact factor: 2.803

View more
  6 in total

Review 1.  Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.

Authors:  Keri Wellington; Monique P Curran
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.

Authors:  Thomas P Lodise; Martina Kinzig-Schippers; George L Drusano; Ulrich Loos; Friedrich Vogel; Jürgen Bulitta; Markus Hinder; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

Review 3.  Cefditoren pivoxil.

Authors:  Malcolm J M Darkes; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 11.431

4.  Dynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997-2012).

Authors:  Mingming He; Kaihu Yao; Wei Shi; Wei Gao; Lin Yuan; Sangjie Yu; Yonghong Yang
Journal:  BMC Infect Dis       Date:  2015-07-11       Impact factor: 3.090

5.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive diseases from Shenzhen Children's Hospital.

Authors:  Xiang Ma; Ruizhen Zhao; Zhuoya Ma; Kaihu Yao; Sangjie Yu; Yuejie Zheng; Yonghong Yang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

6.  Genotype replacement within serotype 23F Streptococcus pneumoniae in Beijing, China: characterization of serotype 23F.

Authors:  X Ma; K H Yao; S J Yu; L Zhou; Q H Li; W Shi; M M He; Y H Yang
Journal:  Epidemiol Infect       Date:  2012-10-16       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.